TLOG OTC
TetraLogic Pharmaceuticals Corporation
1W: +0.0%
1M: +150.0%
3M: +150.0%
YTD: +0.0%
1Y: -50.0%
3Y: -98.0%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$35M
-7.8% ▼
Capital Expenditures
$77K
+85.0% ▲
4Y CAGR: +54.3%
Free Cash Flow
-$35M
-6.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+105.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$19M | -$16M | -$20K | -$36M | -$50M |
| Depreciation & Amort. | $215K | $154K | $100K | $126K | $188K |
| Stock-Based Comp. | $269K | $351K | $4M | $3M | $6M |
| Change in Working Capital | $1M | -$231K | $1M | -$3M | $1M |
| Other Non-Cash Items | $48K | $41K | -$18M | $4M | -$7M |
| Operating Cash Flow | -$17M | -$16M | -$13M | -$32M | -$35M |
| — Investing Activities — | |||||
| Capital Expenditures | -$14K | -$29K | -$67K | -$515K | -$77K |
| Acquisitions (Net) | $0 | $0 | $0 | -$13M | $0 |
| Investment Purchases | -$6M | $0 | $0 | -$66M | -$24M |
| Investment Sales | $500K | $6M | $0 | $26M | $60M |
| Other Investing | $0 | $6K | $0 | $20K | $36K |
| Investing Cash Flow | -$6M | $5M | -$67K | -$54M | $35M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$142K | $5M | $14M | $44M | -$825K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $15K | $2K | $110K | $201K | $31K |
| Financing Cash Flow | $7M | $5M | $63M | $44M | $2M |
| Net Change in Cash | -$16M | -$5M | $51M | -$42M | $2M |
| Cash End of Period | $10M | $5M | $55M | $13M | $15M |
| Free Cash Flow | -$17M | -$16M | -$13M | -$33M | -$35M |